5 potential pitfalls to avoid for successful vaccine trials
6 Nov 2024
John Holtzclaw, scientific advisor at Eurofins Viracor Biopharma, outlines five potential pitfalls in vaccine clinical trials—study timelines, test system suitability, study design and endpoint analysis, sample integrity, and regulatory compliance. He discusses how to mitigate each challenge, emphasizing adapting to evolving regulations and addressing local considerations, especially for global trials. Download the free handout for further detail.
About the company
Eurofins Clinical Trial Solutions
Complex innovative clinical trial designs require an integrated synergetic approach to assess novel drug compounds for safety and effectiveness which often span esoteric, regulated and safety outcomes in all phases of the drug development life cycle. The companies of Eurofins Bioanalytical Services, the Eurofins Central Laboratory global network, Eurofins Viracor BioPharma Services, and Eurofins Clinical Trial Supplies are building a stronger connection to provide a seamless solutions-based approach to our client needs. Eurofins Clinical Trial Solutions provides seamless, end-to-end solutions to help clients progress through the drug development cycle through a single, experienced provider. Our integrated solutions deliver the most comprehensive range of state-of-the-art analytical technologies with an expansive geographic reach in order to support our clients’ specialized testing needs and stringent quality and safety requirements around the world.
